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Intracellular vesicle transport proc‑­
esses depend on the ability of membranes 
to fuse with each other. Such mem‑­
brane fusion is governed by the soluble 
N‑­ethylmaleimide‑­sensitive factor attach‑­
ment protein receptor (SNARE) proteins. 
Neuronal exocytosis requires three SNARE 
proteins, synaptobrevin‑­2 (VAMP2) on 
the synaptic vesicle, and syntaxin‑­1 and 
SNAP‑­25 on the plasma membrane, which 
assemble into a highly stable ternary com‑­
plex essential for membrane fusion. Earlier 
studies have suggested that VAMP2 in syn‑­
aptic vesicles does not readily interact with 
syntaxin‑­1 and SNAP‑­25 (Hu et al., 2002; 
Kweon et al., 2003). Such lack of reactivity 
was attributed to the membrane‑­proximal 
part of VAMP2 interacting with the lipid 
membrane, with positively charged residues 
interacting with negatively charged phos‑­
pholipid headgroups, and two tryptophan 
residues buried in the hydrophobic part of 
the bilayer (Kweon et al., 2003).
A recent study by Darios et al. (2009) 
suggests that sphingosine may stimulate 
the reluctant VAMP2 to engage in fusogenic 
SNARE complexes. Sphingosine was found 
to increase SNARE complex formation 
in vitro, and display a positive effect on neu‑­
rosecretion in a variety of cellular assays. 
The sphingosine‑­mediated enhancement 
likely involves an increase in the readily‑­
releasable vesicle pool, implying regulation 
of a rate‑­limiting event of neurotransmitter 
release. Intriguingly, amongst a panel of 
lipids analysed, the stimulatory effect was 
specific for sphingosine, indicating that this 
lipid plays a direct regulatory role in mem‑­
brane fusion.
This work raises several important ques‑­
tions about the potentiation of SNARE‑­
mediated neurosecretion by sphingosine. 
The first is related to the actual basis 
upon which the work is built, namely that 
VAMP2 is not fully available for SNARE 
complex formation. Indeed, other groups 
have reported that VAMP2 in proteolipo‑­
somes or purified synaptic vesicles readily 
engages in fusion‑­competent SNARE com‑­
plexes, with the rate‑­limiting factor being 
the availability of the SNARE acceptor sites 
on the plasma membrane (Siddiqui et al., 
2007; Holt et al., 2008). The reasons for the 
observed differences in the availability of 
VAMP2 remain unclear, but possible expla‑­
nations include experimental differences 
in the phospholipid composition, protein‑­
lipid ratio and reconstitution procedures 
of liposomes, as well as differences in 
vesicle and protein purification protocols. 
Importantly, whilst vesicular VAMP2 is not 
available for SNARE complex formation 
with wildtype recombinant syntaxin‑­1 and 
SNAP‑­25, a certain degree of complex for‑­
mation was found when using recombinant 
SNAP‑­25 devoid of cysteines (Darios et al., 
2009), a version of SNAP‑­25 used in studies 
demonstrating free availability of VAMP2 
(Siddiqui et al., 2007). Thus, the distinct 
types of SNAP‑­25 employed may account 
for at least part of the observed discrepan‑­
cies. In either case, it will be interesting 
to see whether sphingosine has positive 
modulatory effects upon the kinetics of 
SNARE complex formation even under 
conditions in which VAMP2 seems to be 
freely available.
The second question relates to VAMP2 
being a specific target for sphingosine. The 
best evidence for this comes from observa‑­
tions that sphingosine no longer potentiates 
secretion in VAMP2‑­null mutant neurons 
(Darios et al., 2009). However, it remains 
formally possible that the chronic absence 
of VAMP2 is associated with changes in 
upstream events leading to SNARE complex 
formation upon which sphingosine nor‑­
mally acts. Alternative approaches, such as 
assessing the effects of sphingosine in neu‑­
rons upon transient knockdown of VAMP2 
by RNAi approaches, or in synapses express‑­
ing VAMP2 mutants (Maximov et al., 2009) 
may help to further evaluate specificity of 
sphingosine action with respect to VAMP2. 
In either case, it seems likely that exogenous 
sphingosine will induce additional changes 
in membrane fluidity and curvature which 
may impact upon vesicle fusion in a VAMP2‑­
independent manner.
Assuming that the availability of VAMP2 
for SNARE complex formation is limited, 
the third question arising from the work by 
Darios et al. (2009) is related to exactly how 
sphingosine may regulate the availability of 
VAMP2. The membrane‑­proximal region 
of VAMP2 contains a cluster of basic resi‑­
dues thought to interact with the negatively 
charged phospholipid headgroups, and an 
amphipathic weak base such as sphingosine 
may interfere with this interaction. If this 
were the case, decreasing the net positive 
charge of the membrane‑­proximal region 
of VAMP2 would be expected to enhance 
SNARE complex formation. However, 
mutants which progressively decrease the 
overall net positive charge of this region 
of VAMP2 seem to decrease, rather than 
increase, vesicular secretion (Williams 
et al., 2009). These data have to be inter‑­
preted with care, as a reduction in evoked 
release may be the result of increased 
spontaneous vesicle fusion (i.e. due to a 
run‑­down of the readily‑­releasable pool). 
Alternatively, extensive mutations may 
alter the secondary structure of VAMP2 
in this region. Indeed, recent structural 
data on membrane‑­bound VAMP2 indi‑­
cate the existence of substantial secondary 
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 structure, including a novel N‑­terminal 
motif helix (Ellena et al., 2009). Whilst 
this motif has been proposed to speed up 
subsequent SNARE complex formation 
(Ellena et al., 2009), the availability of such 
structured lipid‑­bound VAMP2 for SNARE 
complex formation remains to be deter‑­
mined, and dynamic structural changes 
induced by the presence of sphingosine 
remain possible.
Irrespective of target specificity, the 
study by Darios et al. (2009) indicates 
that local lipid metabolism can rapidly 
and profoundly affect neurotransmission. 
Whilst the stimulatory effect on release 
seems to mainly involve an increase in the 
readily‑­releasable vesicle pool, sphingo‑­
sine may have multiple and even oppos‑­
ing roles in regulating secretion events, 
dependent on the pool of vesicles under 
study. Sphingosine effects on neurose‑­
cretion may further vary with exposure 
time, with a transient increase leading to 
enhanced transmitter release (Darios et al., 
2009) but a more chronic increase lead‑­
ing to decreased release (Camoletto et al., 
2009). In addition, sphingosine is likely 
to have additional effects on vesicle pool 
turnover. For example, it will be interest‑­
ing to determine whether sphingosine can 
modulate SNARE complex disassembly, 
recently described to be facilitated by the 
membrane interaction of the NSF co‑­factor 
α‑­SNAP (Winter et al., 2009), or whether 
it plays post‑­fusion roles in the recycling 
of VAMP2 upon its dissociation from the 
SNARE complex. Additional vesicular 
fusion events may be affected by sphingo‑­
sine as well, since closely related VAMP2 
isoforms involved in other intracellular 
membrane trafficking also possess the 
positively charged juxtamembrane region 
proposed to be subject to possible regula‑­
tion by lipid interactions.
Finally, since modulating the levels of 
sphingosine and its metabolites is con‑­
sidered a valid novel strategy in treating a 
variety of neurodegenerative diseases such 
as Alzheimer´s, Niemann‑­Pick disease or 
multiple sclerosis, the link between sphin‑­
gosine and regulation of vesicular traffick‑­
ing events described by Darios et al. (2009) 
may help in the description of new molecu‑­
lar disease targets and pathways.
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